Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition

Shaowei Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ravi Bhatia(University of Alabama at Birmingham), Robert S. Welner(Harvard University), Jing Yang(Shanxi Medical University), Nicholas R. Anderson(University of Alabama at Birmingham), David K. Crossman(University of Alabama at Birmingham), Rui Lu(Hebei Medical University), Min Xie(Harbin Medical University), Hui Li(Shanghai Stomatological Hospital), Jianbo He(Otsuka (Japan)), Chengcheng Yan(University of Alabama at Birmingham), Andrew J. Paterson, Harish Kumar(University of Alabama at Birmingham)
Leukemia
October 11, 2022
10.1038/s41375-022-01719-6
Cited by 15

Related Papers

HSPB1 as a novel regulator of ferroptotic cancer cell death
|Oncogene|2015|673
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
|Blood|2003|541
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
|Journal of Clinical Oncology|2013|473